TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients

BACKGROUND: Angiogenesis appears to play an important role in ovarian cancer. Vascular endothelial growth factor (VEGF) has recently been implicated as a therapeutic target in ovarian cancer. The tissue inhibitor of metalloproteinase 1 (TIMP-1) is involved in tissue invasion and angiogenesis. The ap...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Mahner, Sven, Woelber, Linn, Eulenburg, Christine, Schwarz, Joerg, Carney, Walter, Jaenicke, Fritz, Milde-Langosch, Karin, Mueller, Volkmar
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2010
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2873384/
https://ncbi.nlm.nih.gov/pubmed/20388222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-139
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller